Increased mean platelet volume in patients with slow coronary flow

Platelets

Volumn 20, Issue 1, 2009, Pages 23-28

  Sen, Nihat ^a   Basar, Nurcan ^a   Maden, Orhan ^a   Ozcan, Firat ^a   Ozlu, Mehmet Fatih ^a   Gungor, Omer ^a   Cagli, Kumral ^a   Erbay, Ali Riza ^a   Balbay, Yucel ^a  

^a Yuksek Ihtisas Heart Education and Research Hospital   (Turkey)

Author keywords

Mean platelet volume; Platelet; Slow coronary flow; Thrombolysis in myocardial infarction frame count

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLOW CORONARY ARTERY BLOOD FLOW; THROMBOCYTE VOLUME;

BLOOD FLOW VELOCITY; BLOOD PLATELETS; BLOOD PRESSURE; CELL SIZE; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT;

ANGINA; MOROCCAN PEPPER VIRUS;

EID: 61649095213     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802458969     Document Type: Article

References (40)

1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries, a new angiographic finding. Am Heart J 1972;84:66-71.
2. Pekdemir H, Cin VG, Cicek D, Camsari A, Akkus N, Döven O, Parmaksiz HT. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004;59:127-133.
3. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B. et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-1781.
4. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium dependent vasodilation in humans. Circulation 1997;95:1119-1121.
5. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-972.
6. Vrints C, Herman AG. Role of the endothelium in the regulation of coronary artery tone. Acta Cardiol 1991;46:399-418.
7. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177-190.
8. Broadley AJ, Gapper P, Schmitt M, Frenneaux MP. Supine rest reduces platelet activation and aggregation. Platelets 2003;14:3-7.
9. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared tostable angina or non-cardiac chest pain. Eur Heart J 1998;19:80-84.
10. Jagroop IA, Mikhailidis DP. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2003;120:169-170.
11. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161.
12. Ntaios G, Papadopoulos A, Chatzinikolaou A, Saouli Z, Karalazou P, Kaiafa G, Girtovitis F, Kontoninas Z, Savopoulos C, Hatzitolios A. et al. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematol 2008;119:173-177, Epub 2008 May 30.
13. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006;17:67-69.
14. Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications 2004;18:173-176.
15. Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erosalimsky JD. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:802-807.
16. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993;86:739-742.
17. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004;44:415-422.
18. Coban E, Ozdogan M, Yazc?oglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract Aug 2005;59:981-982.
19. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007;120:245-250.
20. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK. et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
21. Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost 1993;70:687-690.
22. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB. Atherosclerosis in angiographically "normal" coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
23. Kelly RF, Sompalli V, Sattar P, Khankari K. Increased TIMI frame counts in cocaine users: A case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol 2003;26:319-322.
24. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, Dell'Italia LJ, Scibilia G, Motta P, Campa PP. Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Catheter Cardiovasc Diagn 1996;37:375-381.
25. Pekdemir H, Polat G, Cin VG, Camsari A, Cicek D, Akkus MN, Doven O, Katircibasi MT, Muslu N. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol 2004;97:35-41.
26. Camsari A, Pekdemir H, Cicek D, Polat G, Akkus MN, Döven O, Cin VG, Katircibasi T, Parmaksiz T. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003;67:1022-1028.
27. Sezgin N, Barutcu I, Sezgin AT, Gullu H, Turkmen M, Esen AM, Karakaya D. Plasma nitric oxide concentration and its role in slow coronary phenomenon. Int Heart J 2005;46:373-382.
28. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-617.
29. Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1998;72:1-8.
30. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-460.
31. Sewell R, Ibbotson RM, Philips R. High mean platelet volume after myocardial infarction: Is it due to consumption of small platelets? Br Med J 1984;289:1576-1580.
32. Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999;101:140-144.
33. Lanza GA, Andreotti F, Sestio A. et al. Platelet aggregability in cardiac syndrome X. Eur Heart J 2001;22:1924-1930.
34. Gökçe M, Kaplan S, Tekeliog̃lu Y, Erdog̃an T, Kũçũkosmanog̃lv M. Platelet function disorder in patients with coronary slow flow. Clin Cardiol 2005;28:145-148.
35. Haubelt H, Simon M, Anders Ch, Hellstern P. Platelet function tests for monitoring of acetylsalicylic acid: Clinical significance in antiplatelet treatment. Hamostaseologie 2004;24:196-202.
36. Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: Analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol 1979;44:39-45.
37. Ge J, Erbel R, Gerber T, Görge G, Koch L, Haode M, Meyer J. Intravascular ultrasound imaging of angiographically normal coronary arteries: A prospective study in vivo. Br Heart J 1994;71:572-578.
38. Abaci A, Oguzhan A, Eryol NK, Ergin A. Effect of potential confounding factors on the thrombolysis in myocardial infarction trial frame count and its reproducibility. Circulation 1999;100:2219-2223.
39. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35:1688-1691.
40. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul. Fibrinolysis 1996;7:157-161.